Investment
Features
FeesSafety
Academy
More
Pluang+

Israel's MAFAT endorses Innoviz LiDAR for defense, highlighting its precision and scalability.

Market News
17 Sep 2026
PRNewsWire
View Source
Bullish
Israel's MAFAT endorses Innoviz LiDAR for defense, highlighting its precision and scalability.

Innoviz Technologies, a leader in automotive-grade LiDAR sensors, has received recognition from MAFAT, the Directorate of Defense Research & Development in Israel. MAFAT acknowledged the maturity, robustness, and performance of Innoviz's LiDAR technology as suitable for various defense applications, including counter-UAS, perimeter security, and critical infrastructure protection. This endorsement underscores the potential of Innoviz's existing LiDAR solutions to enhance defense systems by providing precise sensing capabilities that can improve response times and safety. The recognition may open new opportunities for Innoviz in the defense sector.

Innoviz Technologies' LiDAR capabilities have been recognized by Israel's defense research directorate. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 17, 2026 18:31 WIB: Out of 150 priced US tech stocks, 124 rose and 22 fell. Notable movers include GLW at USD 148.85 (+3.20%), RIOT at USD 21.00 (+3.19%), and TER at USD 351.78 (+3.12%).

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
1 hour ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
2 hours ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
3 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App